Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.
from NDTV News - Special https://ift.tt/2Rxkbqa
from NDTV News - Special https://ift.tt/2Rxkbqa
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
![Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India]()
Reviewed by Latest trending news
on
September 15, 2020
Rating:
No comments:
Note: only a member of this blog may post a comment.